Blue Mountain Appoints Global Head of Marketing to Bolster Growth and Secure its Position as the EAM Industry Standard in the Life Sciences Sector
April 24, 2024 09:00 ET
|
Blue Mountain
STATE COLLEGE, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- Blue Mountain, the leader in GMP-compliant EAM (Enterprise Asset Management) software for life sciences, is pleased to announce the appointment...
Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research
April 23, 2024 08:18 ET
|
Optimi Health Corp.
Optimi Health announces innovative research and development partnership with the Kwantlen Polytechnic University Applied Genomics Centre.
Keiretsu Forum Regions Demonstrate Investment Stability Amidst Industry-Wide Downturns
April 23, 2024 07:29 ET
|
Keiretsu Forum Mid-Atlantic
In 2023, Keiretsu Forum MA-SE-TX region’s curated investment portfolio maintained a confident stance within an otherwise retreating investment ecosystem.
Blue Mountain Achieves SOC 2 Compliance, Demonstrating Commitment to Data Security and Trustworthiness
April 10, 2024 09:00 ET
|
Blue Mountain
STATE COLLEGE, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Blue Mountain, the leader in GMP-compliant EAM (Enterprise Asset Management) software for life sciences, proudly announces its achievement of...
Lily AI’s Co-Founders Purva Gupta and Sowmiya Chocka Narayanan Make Inc.’s 2024 Female Founders List
April 09, 2024 09:15 ET
|
Lily AI
Lily AI’s Co-Founders Purva Gupta and Sowmiya Chocka Narayanan Make Inc.’s 2024 Female Founders List.
Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute
April 09, 2024 09:13 ET
|
Optimi Health Corp.
Optimi signs international natural psilocybin supply agreement with New Zealand-Based Mātai Medical Research Institute, on behalf of the Tū Wairua Project.
Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
April 05, 2024 08:58 ET
|
PharmAla Biotech
PharmAla Biotech announces that its Australian Joint Venture, Cortexa, has initiated manufacturing of LaNeo MDMA in Australia.
Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract
April 02, 2024 07:30 ET
|
Optimi Health Corp.
Optimi receives Certificate Of Analysis for GMP Natural Psilocybin Extract. Company has also completed the in-house encapsulation of 5mg & 10mg psilocybin.
PharmAla Biotech Signs Sale Agreement with Numinus
March 26, 2024 08:55 ET
|
PharmAla Biotech
PharmAla announces binding sales order from Numinus Wellness, as well as a recent presentation of data to the Behaviour, Biology, and Chemistry Conference
CARBOGEN AMCIS announces successful ANVISA audit of its facility in China
March 19, 2024 13:58 ET
|
CARBOGEN AMCIS INNOVATIONS AG
CARBOGEN AMCIS announces successful completion of its first Brazilian Regulatory Authority Agency (ANVISA) routine inspection of its Shanghai facility